Comparative efficacy and safety of symptomatic therapy and disease-modifying therapy for Alzheimer's disease: a systematic review and network meta-analysis. [PDF]
Liu S +7 more
europepmc +1 more source
Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1<i>H</i>)-quinoline-<i>O</i>-carbamate derivatives as AChE/MAO-B dual inhibitors for the treatment of Alzheimer's disease. [PDF]
Fu W +9 more
europepmc +1 more source
Recurrent Cholinergic Crisis Caused by Therapeutic-Dose Rivastigmine Patch in an Elderly Patient With Alzheimer's Disease: A Case Report. [PDF]
Matsuura K +3 more
europepmc +1 more source
Cholinesterase inhibitors in the treatment of Alzheimer's disease [PDF]
Camps Cardenal, Laura +1 more
core
Efficacy of cholinesterase inhibitors and memantine on symptoms not responsive to levodopa in patients affected by Parkinson's disease without dementia: a systematic review. [PDF]
Cani I +11 more
europepmc +1 more source
Comparative safety of cholinesterase inhibitors and memantine for dementia: a protocol for a network meta-analysis of randomized controlled trials. [PDF]
Abouelmagd ME +13 more
europepmc +1 more source
Computational Identification of Potent Multitarget Natural Ligands for Alzheimer's Disease Therapeutics. [PDF]
Sharif N +10 more
europepmc +1 more source
Structure-Based Design of New Series of Sulfonates with Potent and Specific BChE Inhibition and Anti-Inflammatory Effects. [PDF]
Kurma SH +10 more
europepmc +1 more source

